Recent advances in single -
cell genomics technology has made it possible to separate individual cells from different tissues and organs, and measure the sets of RNA messages — called the transcriptome — which help give each cell its own identity.
Not exact matches
Using advances in
genomic sequencing, the human microbiome, proteomics, informatics, computing, and
cell therapy
technologies, HLI is building the world's most comprehensive database of human genotypes and phenotypes as a basis for a variety of commercialization opportunities to help solve aging related disease and human biological decline.
During my tenure at NCI, I redirected my research into expression
genomics, an amalgam of cancer
cell biology and comprehensive and massively parallel genetic
technologies.
Derived mostly from human embryonic kidney 293T (HEK293T) and HeLa
cell lines, EdiGene Knockout (KO) Cell Lysates have been optimized through the use of genome editing technology and validated at the genomic level through PCR and Sanger - sequencing techniques to ensure the accuracy and knockout of the target g
cell lines, EdiGene Knockout (KO)
Cell Lysates have been optimized through the use of genome editing technology and validated at the genomic level through PCR and Sanger - sequencing techniques to ensure the accuracy and knockout of the target g
Cell Lysates have been optimized through the use of genome editing
technology and validated at the
genomic level through PCR and Sanger - sequencing techniques to ensure the accuracy and knockout of the target gene.
«This groundbreaking study sets the stage for more exacting research, using the latest
genomic technologies and aimed at developing new therapies that could help the tens of thousand of patients who urgently need our help,» said Dr. Nhan Tran, an Associate Professor of TGen's Cancer and
Cell Biology Division and the study's other co-senior author.
BERKELEY, CA, and CORALVILLE, IA — February 23, 2016 — Caribou Biosciences, Inc., a developer of CRISPR
technologies for precision
cell engineering, and Integrated DNA
Technologies, Inc. (IDT), a producer of custom synthetic oligonucleotide - based
technologies for
genomics applications, have entered into a non-exclusive license agreement under which Caribou has granted IDT worldwide rights to commercialize CRISPR - Cas9 reagents under Caribou's intellectual property.
Topics for the scientific sessions are: Single
cell genomics and gene expression Genetic interactions RNAi and somatic
cell genetics Protein - DNA interactions Cancer The meeting also highlights existing opportunities for academic and industrial researchers to access automated
cell - based and biochemical
technologies based at the Karolinska High Throughput Center; home to one of the most sophisticated, state - of - the - art, ultra-high performance liquid handling and analysis platforms in Europe.
The new dependency data complement the Dependency Map team's ongoing efforts to use functional
genomic technologies like CRISPR and RNA interference (RNAi) to locate vulnerabilities that arise within cancer
cells as they compensate for the loss of critical genes due to mutations or expression changes.
Using advances in
genomic sequencing, the human microbiome, proteomics, informatics, computing, and
cell therapy
technologies, HLI is building the world's most comprehensive database of human genotypes and phenotypes as a basis for a variety of commercialization opportunities to help solve aging related disease and human biological decline.
Single
cell genomics is an emerging
technology enabling the exploration of genomes of individual microbial
cells without the need for prior cultivation.
These types of investigations have been enabled by key
technologies, including single -
cell assays, high - throughput
genomic sequencing, and improved bioinformatic algorithms.
In a study being published online today in the journal
Cell, researchers in the laboratory of Gladstone Senior Investigator Benoit Bruneau, PhD, employed stem cell technology, next - generation DNA sequencing and computing tools to piece together the instruction manual, or «genomic blueprint» for how a heart becomes a he
Cell, researchers in the laboratory of Gladstone Senior Investigator Benoit Bruneau, PhD, employed stem
cell technology, next - generation DNA sequencing and computing tools to piece together the instruction manual, or «genomic blueprint» for how a heart becomes a he
cell technology, next - generation DNA sequencing and computing tools to piece together the instruction manual, or «
genomic blueprint» for how a heart becomes a heart.
We employ a wide variety of state - of - the - art
technologies such as in vivo optical imaging and high - throughput methods including
cell - based screening,
genomics, and proteomics approaches.
Scientific programs include: human
genomic sequencing and analysis, synthetic
genomics and exploration of new vaccines using this
technology, and environmental and single
cell genomics to explore the vast unseen world of microbes living in the human body, the ocean, soil and air.
My lab is dedicated to explore the vast uncharacterized microbial diversity using cutting - edge culture independent
technologies, such as single
cell genomics and metagenomics.
Cell biology has continued to expand ever since, extending its impact on clinical medicine and pharmacology while drawing on new
technologies in bioengineering, high - resolution imaging, massive data handling, and
genomic sequencing.
In the past few years, FANTOM researchers have applied Cap Analysis Gene Expression (CAGE), a
genomic technology developed at RIKEN, to numerous mammalian
cell and tissue types.
Topics covered include embryonic stem
cells, pluripotency, germline stem
cells, tissue - specific stem
cells, stem
cell differentiation, epigenetics, stem
cell genomics and systems biology, genome reprogramming, cancer stem
cells, stem
cell niches, stem -
cell - based disease models, nuclear transfer
technology, bioengineering, drug discovery, in vivo imaging of stem
cells, therapeutic applications, regenerative medicine, clinical and translational insights, stem
cell research policies, ethical issues, and technical or resource - based innovations.
With the recent advances in
technologies, we are now able to map the epigenetic differences between normal and cancer
cells at a
genomic scale with high efficiency.
Recognizing the remarkable opportunities to apply single
cell technologies to major questions in biology and medicine, JAX recently launched a joint center for single
cell genomics together with the University of Connecticut, including UConn Health.
To pursue these studies, we employ Hi - C and ChIA - PET
genomic technologies and single locus / live -
cell imaging approach.
To pursue these studies, the Noma laboratory employs
genomic technologies and single locus / live -
cell imaging
technology along with molecular and chromatin biology and epigenetics.
He is Director of Genetics at the San Diego Zoo Institute for Conservation Research and oversees research efforts in
cell culture and cryobanking, cytogenetics, population genetics, conservation breeding, evolution and systematics, and applications of
genomics technologies to conservation efforts for managed and wild populations of threatened and endangered species.
Sapphire Energy has not provided many details publicly about its
technology except to say that it doesn't need fresh water to grow the algae and that it has assembled a team with expertise in
cell biology, plant
genomics, and algal production.
Stand for Science highlights the history of federal investments in
technology, from lasers and
genomics to
cell phones and the Internet.